Cargando…
Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used new-generation drugs for depression. Depressive symptoms are thought to be closely related to neuroinflammation. In this study, we used up-to-date protocols of cultu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890881/ https://www.ncbi.nlm.nih.gov/pubmed/33602262 http://dx.doi.org/10.1186/s12974-021-02097-z |
_version_ | 1783652588093177856 |
---|---|
author | He, Jia-Hui Liu, Rong-Pei Peng, Yi-Man Guo, Qing Zhu, Lan-Bing Lian, Yi-Zhi Hu, Bei-Lei Fan, Hui-Hui Zhang, Xiong Zhu, Jian-Hong |
author_facet | He, Jia-Hui Liu, Rong-Pei Peng, Yi-Man Guo, Qing Zhu, Lan-Bing Lian, Yi-Zhi Hu, Bei-Lei Fan, Hui-Hui Zhang, Xiong Zhu, Jian-Hong |
author_sort | He, Jia-Hui |
collection | PubMed |
description | BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used new-generation drugs for depression. Depressive symptoms are thought to be closely related to neuroinflammation. In this study, we used up-to-date protocols of culture and stimulation and aimed to understand how astrocytes respond to the antidepressants. METHODS: Primary astrocytes were isolated and cultured using neurobasal-based serum-free medium. The cells were treated with a cytokine mixture comprising complement component 1q, tumor necrosis factor α, and interleukin 1α with or without pretreatments of antidepressants. Cell viability, phenotypes, inflammatory responses, and the underlying mechanisms were analyzed. RESULTS: All the SSRIs, including paroxetine, fluoxetine, sertraline, citalopram, and fluvoxamine, show a visible cytotoxicity within the range of applied doses, and a paradoxical effect on astrocytic inflammatory responses as manifested by the promotion of inducible nitric oxide synthase (iNOS) and/or nitric oxide (NO) and the inhibition of interleukin 6 (IL-6) and/or interleukin 1β (IL-1β). The SNRI venlafaxine was the least toxic to astrocytes and inhibited the production of IL-6 and IL-1β but with no impact on iNOS and NO. All the drugs had no regulation on the polarization of astrocytic A1 and A2 types. Mechanisms associated with the antidepressants in astrocytic inflammation route via inhibition of JNK1 activation and STAT3 basal activity. CONCLUSIONS: The study demonstrated that the antidepressants possess differential cytotoxicity to astrocytes and function differently, also paradoxically for the SSRIs, to astrocytic inflammation. Our results provide novel pieces into understanding the differential efficacy and tolerability of the antidepressants in treating patients in the context of astrocytes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-021-02097-z. |
format | Online Article Text |
id | pubmed-7890881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78908812021-02-22 Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation He, Jia-Hui Liu, Rong-Pei Peng, Yi-Man Guo, Qing Zhu, Lan-Bing Lian, Yi-Zhi Hu, Bei-Lei Fan, Hui-Hui Zhang, Xiong Zhu, Jian-Hong J Neuroinflammation Research BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used new-generation drugs for depression. Depressive symptoms are thought to be closely related to neuroinflammation. In this study, we used up-to-date protocols of culture and stimulation and aimed to understand how astrocytes respond to the antidepressants. METHODS: Primary astrocytes were isolated and cultured using neurobasal-based serum-free medium. The cells were treated with a cytokine mixture comprising complement component 1q, tumor necrosis factor α, and interleukin 1α with or without pretreatments of antidepressants. Cell viability, phenotypes, inflammatory responses, and the underlying mechanisms were analyzed. RESULTS: All the SSRIs, including paroxetine, fluoxetine, sertraline, citalopram, and fluvoxamine, show a visible cytotoxicity within the range of applied doses, and a paradoxical effect on astrocytic inflammatory responses as manifested by the promotion of inducible nitric oxide synthase (iNOS) and/or nitric oxide (NO) and the inhibition of interleukin 6 (IL-6) and/or interleukin 1β (IL-1β). The SNRI venlafaxine was the least toxic to astrocytes and inhibited the production of IL-6 and IL-1β but with no impact on iNOS and NO. All the drugs had no regulation on the polarization of astrocytic A1 and A2 types. Mechanisms associated with the antidepressants in astrocytic inflammation route via inhibition of JNK1 activation and STAT3 basal activity. CONCLUSIONS: The study demonstrated that the antidepressants possess differential cytotoxicity to astrocytes and function differently, also paradoxically for the SSRIs, to astrocytic inflammation. Our results provide novel pieces into understanding the differential efficacy and tolerability of the antidepressants in treating patients in the context of astrocytes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-021-02097-z. BioMed Central 2021-02-18 /pmc/articles/PMC7890881/ /pubmed/33602262 http://dx.doi.org/10.1186/s12974-021-02097-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research He, Jia-Hui Liu, Rong-Pei Peng, Yi-Man Guo, Qing Zhu, Lan-Bing Lian, Yi-Zhi Hu, Bei-Lei Fan, Hui-Hui Zhang, Xiong Zhu, Jian-Hong Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation |
title | Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation |
title_full | Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation |
title_fullStr | Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation |
title_full_unstemmed | Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation |
title_short | Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation |
title_sort | differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890881/ https://www.ncbi.nlm.nih.gov/pubmed/33602262 http://dx.doi.org/10.1186/s12974-021-02097-z |
work_keys_str_mv | AT hejiahui differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT liurongpei differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT pengyiman differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT guoqing differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT zhulanbing differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT lianyizhi differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT hubeilei differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT fanhuihui differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT zhangxiong differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation AT zhujianhong differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation |